101 related articles for article (PubMed ID: 24218026)
1. Epstein-Barr virus is rarely associated with diffuse large B cell lymphoma in Taiwan and carries a trend for a shorter median survival time.
Chang ST; Lu YH; Lu CL; Weng SF; Lin SH; Kuo SY; Chuang YT; Takeuchi K; Ohshima K; Chuang SS
J Clin Pathol; 2014 Apr; 67(4):326-32. PubMed ID: 24218026
[TBL] [Abstract][Full Text] [Related]
2. Epstein-Barr virus infection and expression of B-cell oncogenic markers in HIV-related diffuse large B-cell Lymphoma.
Chao C; Silverberg MJ; Martínez-Maza O; Chi M; Abrams DI; Haque R; Zha HD; McGuire M; Xu L; Said J
Clin Cancer Res; 2012 Sep; 18(17):4702-12. PubMed ID: 22711707
[TBL] [Abstract][Full Text] [Related]
3. Cytotoxic response against Epstein Barr virus coexists with diffuse large B-cell lymphoma tolerogenic microenvironment: clinical features and survival impact.
Cohen M; Vistarop AG; Huaman F; Narbaitz M; Metrebian F; De Matteo E; Preciado MV; Chabay PA
Sci Rep; 2017 Sep; 7(1):10813. PubMed ID: 28883511
[TBL] [Abstract][Full Text] [Related]
4. Estimating the global burden of Epstein-Barr virus-related cancers.
Wong Y; Meehan MT; Burrows SR; Doolan DL; Miles JJ
J Cancer Res Clin Oncol; 2022 Jan; 148(1):31-46. PubMed ID: 34705104
[TBL] [Abstract][Full Text] [Related]
5. Clinicopathological features and survival in EBV-positive diffuse large B-cell lymphoma not otherwise specified.
Bourbon E; Maucort-Boulch D; Fontaine J; Mauduit C; Sesques P; Safar V; Ferrant E; Golfier C; Ghergus D; Karlin L; Lazareth A; Bouafia F; Pica GM; Orsini-Piocelle F; Rocher C; Gros FX; Parrens M; Dony A; Rossi C; Ghesquières H; Bachy E; Traverse-Glehen A; Sarkozy C
Blood Adv; 2021 Aug; 5(16):3227-3239. PubMed ID: 34427583
[TBL] [Abstract][Full Text] [Related]
6. Clinicopathological evaluation of methotrexate-associated lymphoproliferative disorders with special focus on Epstein-Barr virus-positive mucocutaneous lesions.
Shiraiwa S; Kikuti YY; Carreras J; Hara R; Aoyama Y; Ogiya D; Suzuki R; Toyosaki M; Ohmachi K; Ogawa Y; Kawada H; Sato S; Nakamura N; Ando K
J Clin Exp Hematop; 2020 Dec; 60(4):159-168. PubMed ID: 33148934
[TBL] [Abstract][Full Text] [Related]
7. Frequent expression of PD-L1 in BLS-type diffuse large B-cell lymphoma: implications for aggressiveness and immunotherapy.
Yang CF; Yu YT; Wang SH; Chen YP; Chen TY; Hsu CY; Medeiros LJ; Chang KC
Pathology; 2024 Apr; 56(3):367-373. PubMed ID: 38290893
[TBL] [Abstract][Full Text] [Related]
8. Presence of Epstein-Barr virus (EBV) antigens detected by sensitive methods has no influence on local immune environment in diffuse large B cell lymphoma.
Mangiaterra T; Alonso-Alonso R; Rabinovich A; De Dios Soler M; Galluzzo L; Soria M; Colli S; De Matteo E; Rodriguez Pinilla SM; Chabay P
Cancer Immunol Immunother; 2024 Jan; 73(2):29. PubMed ID: 38280007
[TBL] [Abstract][Full Text] [Related]
9. VR09 cell line: an EBV-positive lymphoblastoid cell line with in vivo characteristics of diffuse large B cell lymphoma of activated B-cell type.
Nichele I; Zamò A; Bertolaso A; Bifari F; Tinelli M; Franchini M; Stradoni R; Aprili F; Pizzolo G; Krampera M
PLoS One; 2012; 7(12):e52811. PubMed ID: 23285191
[TBL] [Abstract][Full Text] [Related]
10. HHV-8-positive and EBV-positive intravascular lymphoma: an unusual presentation of extracavitary primary effusion lymphoma.
Crane GM; Ambinder RF; Shirley CM; Fishman EK; Kasamon YL; Taube JM; Borowitz MJ; Duffield AS
Am J Surg Pathol; 2014 Mar; 38(3):426-32. PubMed ID: 24525514
[TBL] [Abstract][Full Text] [Related]
11. Improved survival of gastric cancer with tumour Epstein-Barr virus positivity: an international pooled analysis.
Camargo MC; Kim WH; Chiaravalli AM; Kim KM; Corvalan AH; Matsuo K; Yu J; Sung JJ; Herrera-Goepfert R; Meneses-Gonzalez F; Kijima Y; Natsugoe S; Liao LM; Lissowska J; Kim S; Hu N; Gonzalez CA; Yatabe Y; Koriyama C; Hewitt SM; Akiba S; Gulley ML; Taylor PR; Rabkin CS
Gut; 2014 Feb; 63(2):236-43. PubMed ID: 23580779
[TBL] [Abstract][Full Text] [Related]
12. Comprehensive Genomic Profiling of EBV-Positive Diffuse Large B-cell Lymphoma and the Expression and Clinicopathological Correlations of Some Related Genes.
Zhou Y; Xu Z; Lin W; Duan Y; Lu C; Liu W; Su W; Yan Y; Liu H; Liu L; Zhong M; Zhou J; Zhu H
Front Oncol; 2019; 9():683. PubMed ID: 31403034
[TBL] [Abstract][Full Text] [Related]
13. Cytological Features of Fibrin-associated Diffuse Large B-cell Lymphoma Arising in Retroperitoneal Pseudocyst: The First Case Report.
Na K; Kim SW; Kim HS
In Vivo; 2024; 38(3):1477-1482. PubMed ID: 38688594
[TBL] [Abstract][Full Text] [Related]
14. Epstein-Barr Virus-Positive Plasma Cell Neoplasms in Immunocompetent Patients: A Clinicopathological Study of 15 Cases from South China and Literature Review.
Xiao S; Lin Y; Fu J; Weng X; Cao Q; Kuang Z; Yun J; Zhang M; Huang Y
Am J Surg Pathol; 2024 Jan; 48(1):16-26. PubMed ID: 38117285
[TBL] [Abstract][Full Text] [Related]
15. Gene expression profiling of gray zone lymphoma.
Sarkozy C; Chong L; Takata K; Chavez EA; Miyata-Takata T; Duns G; Telenius A; Boyle M; Slack GW; Laurent C; Farinha P; Molina TJ; Copie-Bergman C; Damotte D; Salles GA; Mottok A; Savage KJ; Scott DW; Traverse-Glehen A; Steidl C
Blood Adv; 2020 Jun; 4(11):2523-2535. PubMed ID: 32516416
[TBL] [Abstract][Full Text] [Related]
16. The biology and treatment of Epstein-Barr virus-positive diffuse large B cell lymphoma, NOS.
Li JW; Deng C; Zhou XY; Deng R
Heliyon; 2024 Jan; 10(1):e23921. PubMed ID: 38234917
[TBL] [Abstract][Full Text] [Related]
17. Clinicopathological features of a rare cancer: Intrahepatic lymphoepithelioma-like cholangiocarcinoma with Epstein-Barr virus infection.
Zheng L; Zhou N; Yang X; Wei Y; Yi C; Gou H
Clin Res Hepatol Gastroenterol; 2023 Dec; 47(10):102244. PubMed ID: 37944749
[TBL] [Abstract][Full Text] [Related]
18. Estimating the prevalence of Epstein-Barr virus in primary gastric lymphoma: a systematic review and meta-analysis.
Hirabayashi M; Traverse-Glehen A; Combes JD; Clifford GM; de Martel C
Infect Agent Cancer; 2023 Feb; 18(1):8. PubMed ID: 36765388
[TBL] [Abstract][Full Text] [Related]
19. Clinicopathological Characteristics and Prognosis of Diffuse Large B-Cell Lymphoma in Relation to CA-125 and CA 19-9 Expression.
Foda AAM; Atia T; Sakr HI; Abd Elaziz Ahmed Elnaghi K; Abdelhay WM; Enan ET
J Evid Based Integr Med; 2023; 28():2515690X231198315. PubMed ID: 37654084
[No Abstract] [Full Text] [Related]
20. EBV-negative Fibrin-Associated Large B-Cell Lymphoma Arising in Thyroid Hyperplastic Nodule: Report of a Case and Literature Review.
Ho TW; Cheuk W; Chan JKC
Int J Surg Pathol; 2023 Oct; 31(7):1420-1425. PubMed ID: 36843554
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
